Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FATE | INZY | GNFT | ||
| Company | Fate Therapeutics | Inozyme Pharma Inc | Genfit S.A. ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.6750 | 2.77 | 3.71 | ||
| High | 1.8000 | 3.03 | 3.80 | ||
| Low | 1.6404 | 2.75 | 3.70 | ||
| Last | 1.6800 | 2.99 | 3.80 | ||
| Change | +0.0200 | +0.18 | +0.08 | ||
| % Change | +1.20% | +6.41% | +2.15% | ||
| Volume | 10,135,900 | 932,200 | 3,100 | ||
| 20-Day Average Volume | 4,385,955 | 920,425 | 9,800 | ||
| Previous Close | 1.6600 | 2.81 | 3.72 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 2.3372 | 2.79 | 3.97 | ||
| 20-Day Raw Stochastic | 4.89% | 56.28% | 21.03% | ||
| 20-Day Relative Strength | 37.75% | 42.34% | 35.41% | ||
| Weighted Alpha | -69.17 | -47.78 | -2.84 | ||
| Today's Opinion | 100% Sell | 88% Sell | 40% Sell | ||
| Previous Opinion | 100% Sell | 88% Sell | 40% Sell | ||
| Last Month's Opinion | 100% Sell | 100% Sell | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.20% since 12/13/24 | -1.32% since 12/13/24 | -0.52% since 12/13/24 | ||
| Low | 1.5900 on 12/19/24 | 2.65 on 12/19/24 | 3.63 on 12/17/24 | ||
| High | 2.0650 on 12/16/24 | 3.28 on 12/16/24 | 3.93 on 12/19/24 | ||
| 1-Month | |||||
| %Chg | -24.32% since 11/20/24 | +7.17% since 11/20/24 | -11.83% since 11/20/24 | ||
| Low | 1.5900 on 12/19/24 | 2.38 on 12/06/24 | 3.63 on 12/17/24 | ||
| High | 3.4300 on 11/29/24 | 3.46 on 12/12/24 | 4.45 on 11/25/24 | ||
| 3-Month | |||||
| %Chg | -56.59% since 09/20/24 | -47.82% since 09/20/24 | -21.49% since 09/20/24 | ||
| Low | 1.5900 on 12/19/24 | 2.38 on 12/06/24 | 3.63 on 12/17/24 | ||
| High | 3.9000 on 09/23/24 | 5.73 on 09/23/24 | 6.42 on 10/17/24 | ||
| 6-Month | |||||
| %Chg | -53.20% since 06/20/24 | -32.05% since 06/20/24 | -5.24% since 06/20/24 | ||
| Low | 1.5900 on 12/19/24 | 2.38 on 12/06/24 | 3.61 on 06/28/24 | ||
| High | 5.9200 on 07/26/24 | 6.24 on 09/17/24 | 6.42 on 10/17/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 191,342 | 192,078 | 189,973 | ||
| Shares Outstanding, K | 113,894 | 64,240 | 49,993 | ||
| Annual Sales | 63,530,000 | 0 | 41,320,000 | ||
| Annual Net Income | -160,930,000 | -71,170,000 | -31,270,000 | ||
| Last Quarter Sales | 3,070,000 | 0 | 14,265,000 | ||
| Last Quarter Net Income | -47,680,000 | -24,570,000 | N/A | ||
| 60-Month Beta | 1.95 | 1.37 | 1.14 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.40 on 11/12/24 | -0.39 on 11/05/24 | N/A | ||
| Latest Earnings Date | 11/13/24 | 11/05/24 | 07/04/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||